布来鲁单抗
| 单克隆抗体 | |
|---|---|
| 种类 | 完整抗体 |
| 目標 | CD40 |
| 臨床資料 | |
| 其他名稱 | ASKP1240 |
| ATC碼 |
|
| 识别信息 | |
| CAS号 | 1453067-91-8 |
| ChemSpider |
|
| UNII | |
| KEGG | |
| 化学信息 | |
| 化学式 | C6412H9906N1690O2018S38 |
| 摩尔质量 | 144,175.87 g·mol−1 |
布来鲁单抗（INN：bleselumab；开发代号：ASKP1240）是一种人单克隆抗体，设计用于预防器官移植排斥。[1][2]
参考资料[编辑]
- ^ Wojciechowski D, Vincenti F. Current status of costimulatory blockade in renal transplantation. Current Opinion in Nephrology and Hypertension. November 2016, 25 (6): 583–590. PMID 27517137. S2CID 4379881. doi:10.1097/MNH.0000000000000268.
- ^ Malvezzi P, Jouve T, Rostaing L. Costimulation Blockade in Kidney Transplantation: An Update. Transplantation. November 2016, 100 (11): 2315–2323. PMC 5084636
. PMID 27472094. doi:10.1097/TP.0000000000001344.
- ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Bleselumab, American Medical Association.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||